The event will take place on November 21 in Basel.
Individualized CAR‑T therapy uses a patient’s own immune system to fight certain types of cancers.
Newly released survey findings shed light on the daily challenges associated with cataracts and the emotional benefits of improved vision after surgery. Nearly all survey respondents said they would recommend cataract surgery based on their personal experiences.
More than 300 million people live with asthma globally, and 6 million do not adequately control their symptoms. In a new European survey of nearly 1,000 severe asthma patients, 88% reported the condition impacted their daily lives, and almost the same amount (84%) said asthma limited their physical activity.
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
Through a successful patient support program, Novartis is taking diabetes care beyond the pill in India.
Health experts from around the world met November 29 to discuss ways to tackle an emerging crisis.
A recent summit explored how technological advances could impact patient care.
We teamed up with Medikidz and the COPD Foundation to develop a creative way to explain COPD to children.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
For media and journalist inquiries, please contact the Novartis Corporate Media Relations office by email or telephone.
Central Media Line:Phone: +41 61 324 2200
This site is intended for a global audience.